101 related articles for article (PubMed ID: 23167414)
1. Combined EGFR and c-Src antisense oligodeoxynucleotides encapsulated with PAMAM Denderimers inhibit HT-29 colon cancer cell proliferation.
Nourazarian AR; Najar AG; Farajnia S; Khosroushahi AY; Pashaei-Asl R; Omidi Y
Asian Pac J Cancer Prev; 2012; 13(9):4751-6. PubMed ID: 23167414
[TBL] [Abstract][Full Text] [Related]
2. EGFR antisense oligonucleotides encapsulated with nanoparticles decrease EGFR, MAPK1 and STAT5 expression in a human colon cancer cell line.
Najar AG; Pashaei-Asl R; Omidi Y; Farajnia S; Nourazarian AR
Asian Pac J Cancer Prev; 2013; 14(1):495-8. PubMed ID: 23534780
[TBL] [Abstract][Full Text] [Related]
3. c-Src antisense complexed with PAMAM denderimes decreases of c-Src expression and EGFR-dependent downstream genes in the human HT-29 colon cancer cell line.
Nourazarian AR; Pashaei-Asl R; Omidi Y; Najar AG
Asian Pac J Cancer Prev; 2012; 13(5):2235-40. PubMed ID: 22901200
[TBL] [Abstract][Full Text] [Related]
4. Bioimpacts of anti epidermal growth factor receptor antisense complexed with polyamidoamine dendrimers in human lung epithelial adenocarcinoma cells.
Nakhlband A; Barar J; Bidmeshkipour A; Heidari HR; Omidi Y
J Biomed Nanotechnol; 2010 Aug; 6(4):360-9. PubMed ID: 21323109
[TBL] [Abstract][Full Text] [Related]
5. Messenger RNA expression profiling of genes involved in epidermal growth factor receptor signalling in human cancer cells treated with scanning array-designed antisense oligonucleotides.
Petch AK; Sohail M; Hughes MD; Benter I; Darling J; Southern EM; Akhtar S
Biochem Pharmacol; 2003 Sep; 66(5):819-30. PubMed ID: 12948863
[TBL] [Abstract][Full Text] [Related]
6. Interacting post-muscarinic receptor signaling pathways potentiate matrix metalloproteinase-1 expression and invasion of human colon cancer cells.
Said AH; Hu S; Abutaleb A; Watkins T; Cheng K; Chahdi A; Kuppusamy P; Saxena N; Xie G; Raufman JP
Biochem J; 2017 Feb; 474(5):647-665. PubMed ID: 28008134
[TBL] [Abstract][Full Text] [Related]
7. PGE2/EP3/SRC signaling induces EGFR nuclear translocation and growth through EGFR ligands release in lung adenocarcinoma cells.
Bazzani L; Donnini S; Finetti F; Christofori G; Ziche M
Oncotarget; 2017 May; 8(19):31270-31287. PubMed ID: 28415726
[TBL] [Abstract][Full Text] [Related]
8. Activation of proteinase-activated receptor 1 promotes human colon cancer cell proliferation through epidermal growth factor receptor transactivation.
Darmoul D; Gratio V; Devaud H; Peiretti F; Laburthe M
Mol Cancer Res; 2004 Sep; 2(9):514-22. PubMed ID: 15383630
[TBL] [Abstract][Full Text] [Related]
9. Antisense oligonucleotides to the epidermal growth factor receptor.
Witters L; Kumar R; Mandal M; Bennett CF; Miraglia L; Lipton A
Breast Cancer Res Treat; 1999 Jan; 53(1):41-50. PubMed ID: 10206071
[TBL] [Abstract][Full Text] [Related]
10. Decreased tumorigenicity of a human colon adenocarcinoma cell line by an antisense expression vector specific for c-Src.
Staley CA; Parikh NU; Gallick GE
Cell Growth Differ; 1997 Mar; 8(3):269-74. PubMed ID: 9056668
[TBL] [Abstract][Full Text] [Related]
11. Deoxycholic acid mediates non-canonical EGFR-MAPK activation through the induction of calcium signaling in colon cancer cells.
Centuori SM; Gomes CJ; Trujillo J; Borg J; Brownlee J; Putnam CW; Martinez JD
Biochim Biophys Acta; 2016 Jul; 1861(7):663-70. PubMed ID: 27086143
[TBL] [Abstract][Full Text] [Related]
12. The influence of STAT5 antisense oligodeoxynucleotides on the proliferation and apoptosis of selected human cutaneous T-cell lymphoma cell lines.
Baśkiewicz-Masiuk M; Walczak M; Grzegrzółka R; Rogowska D; Machaliński B
Arch Dermatol Res; 2006 Apr; 297(10):450-8. PubMed ID: 16502315
[TBL] [Abstract][Full Text] [Related]
13. Combined targeting of epidermal growth factor receptor and MDM2 by gefitinib and antisense MDM2 cooperatively inhibit hormone-independent prostate cancer.
Bianco R; Caputo R; Caputo R; Damiano V; De Placido S; Ficorella C; Agrawal S; Bianco AR; Ciardiello F; Tortora G
Clin Cancer Res; 2004 Jul; 10(14):4858-64. PubMed ID: 15269162
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of p185c-erbB-2 proto-oncogene expression by antisense oligodeoxynucleotides down-regulates p185-associated tyrosine-kinase activity and strongly inhibits mammary tumor-cell proliferation.
Brysch W; Magal E; Louis JC; Kunst M; Klinger I; Schlingensiepen R; Schlingensiepen KH
Cancer Gene Ther; 1994 Jun; 1(2):99-105. PubMed ID: 7621247
[TBL] [Abstract][Full Text] [Related]
15. The Antitumor Activity of hAMSCs Secretome in HT-29 Colon Cancer Cells Through Downregulation of EGFR/c-Src/IRTKS Expression and p38/ERK1/2 Phosphorylation.
Ebadi Zavieh S; Safari F
Cell Biochem Biophys; 2022 Jun; 80(2):395-402. PubMed ID: 35150389
[TBL] [Abstract][Full Text] [Related]
16. c-Src/Cav1-dependent activation of the EGFR by Dsg2.
Overmiller AM; McGuinn KP; Roberts BJ; Cooper F; Brennan-Crispi DM; Deguchi T; Peltonen S; Wahl JK; Mahoney MG
Oncotarget; 2016 Jun; 7(25):37536-37555. PubMed ID: 26918609
[TBL] [Abstract][Full Text] [Related]
17. Aberrant expression of proteinase-activated receptor 4 promotes colon cancer cell proliferation through a persistent signaling that involves Src and ErbB-2 kinase.
Gratio V; Walker F; Lehy T; Laburthe M; Darmoul D
Int J Cancer; 2009 Apr; 124(7):1517-25. PubMed ID: 19058300
[TBL] [Abstract][Full Text] [Related]
18. Cooperative inhibition of renal cancer growth by anti-epidermal growth factor receptor antibody and protein kinase A antisense oligonucleotide.
Ciardiello F; Caputo R; Bianco R; Damiano V; Pomatico G; Pepe S; Bianco AR; Agrawal S; Mendelsohn J; Tortora G
J Natl Cancer Inst; 1998 Jul; 90(14):1087-94. PubMed ID: 9672257
[TBL] [Abstract][Full Text] [Related]
19. Chemosensitization and delayed androgen-independent recurrence of prostate cancer with the use of antisense Bcl-2 oligodeoxynucleotides.
Miayake H; Tolcher A; Gleave ME
J Natl Cancer Inst; 2000 Jan; 92(1):34-41. PubMed ID: 10620631
[TBL] [Abstract][Full Text] [Related]
20. (-)-Epigallocatechin gallate and polyphenon E inhibit growth and activation of the epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells.
Shimizu M; Deguchi A; Lim JT; Moriwaki H; Kopelovich L; Weinstein IB
Clin Cancer Res; 2005 Apr; 11(7):2735-46. PubMed ID: 15814656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
